Vanguard Capital Management
JAZZ icon

Vanguard Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Vanguard Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658M Buy
2,729,650
+81,317
+3% +$17.8M 0.01% 616
2026
Q1 		$501M Buy
+2,648,333
New +$463M 0.01% 670

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management's JAZZ Position: Q2 2026 in Review

Vanguard Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 3.1% in Q2 2026, buying an estimated $17.8M and bringing the position to 2,729,650 shares worth $658M. The position accounts for 0.01% of the portfolio, ranked #616.

Vanguard Capital Management first reported a position in JAZZ in Q1 2026 and has held it in 2 quarters since. 602 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Vanguard Capital Management held 2,729,650 shares of Jazz Pharmaceuticals worth $658M as of Q2 2026.
  • Vanguard Capital Management bought 81,317 Jazz Pharmaceuticals shares in Q2 2026, an estimated $17.8M.
  • Jazz Pharmaceuticals made up 0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #616 holding.
  • Vanguard Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 602 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.